Global Single Lead ECG Equipment Market to Reach $508.4 Million by 2027
Abstract: - Global Single Lead ECG Equipment Market to Reach $508. 4 Million by 2027. - Amid the COVID-19 crisis, the global market for Single Lead ECG Equipment estimated at US$372.
New York, June 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Single Lead ECG Equipment Industry" - https://www.reportlinker.com/p06032880/?utm_source=GNW
5 Million in the year 2020, is projected to reach a revised size of US$508.4 Million by 2027, growing at a CAGR of 4.5% over the analysis period 2020-2027. Syncope, one of the segments analyzed in the report, is projected to record a 4.3% CAGR and reach US$216.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Arrhythmia segment is readjusted to a revised 4.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $100.6 Million, While China is Forecast to Grow at 7.3% CAGR
- The Single Lead ECG Equipment market in the U.S. is estimated at US$100.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$105.1 Million by the year 2027 trailing a CAGR of 7.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
- Other Indications Segment to Record 4.3% CAGR
- In the global Other Indications segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$44.6 Million in the year 2020 will reach a projected size of US$58.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68 Million by the year 2027, while Latin America will expand at a 4.6% CAGR through the analysis period.
- Select Competitors (Total 42 Featured) -
AliveCor, Inc.
Ambisea Technology Corp., Ltd
Contec Medical Systems Co., Ltd.
DailyCare BioMedical Inc.
Dimetek Digital Medical Technologies, Ltd
Eurocamina
Lohman Technologies
Longfian Scitech Co., Ltd.
Omron Healthcare, Inc.
Perlong Medical Equipment Co., Ltd.
Qardio, Inc.
SUZUKEN CO., LTD
Tianjin Chase Sun Pharmaceutical Group (Beijing Choice Electronic Tech Co., Ltd)
Zenicor Medical Systems AB
Read the full report: https://www.reportlinker.com/p06032880/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Single Lead ECG
Equipment by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Single Lead ECG Equipment by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Single Lead ECG
Equipment by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027
Table 4: World Current & Future Analysis for Syncope by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 5: World Historic Review for Syncope by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 6: World 15-Year Perspective for Syncope by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Arrhythmia by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Arrhythmia by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Arrhythmia by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Other Indications
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Other Indications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Other Indications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Home Care by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Home Care by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for Home Care by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Ambulatory
Surgical Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
III. MARKET ANALYSIS
UNITED STATES
Table 22: USA Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 23: USA Historic Review for Single Lead ECG Equipment by
Indication - Syncope, Arrhythmia and Other Indications Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 24: USA 15-Year Perspective for Single Lead ECG Equipment
by Indication - Percentage Breakdown of Value Sales for
Syncope, Arrhythmia and Other Indications for the Years 2012,
2020 & 2027
Table 25: USA Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 26: USA Historic Review for Single Lead ECG Equipment by
End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 27: USA 15-Year Perspective for Single Lead ECG Equipment
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Clinics, Home Care and Ambulatory Surgical Centers for the
Years 2012, 2020 & 2027
CANADA
Table 28: Canada Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 29: Canada Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 30: Canada 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 31: Canada Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 32: Canada Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 33: Canada 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
JAPAN
Table 34: Japan Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 35: Japan Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 36: Japan 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 37: Japan Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 38: Japan Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 39: Japan 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
CHINA
Table 40: China Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 41: China Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 42: China 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 43: China Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 44: China Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 45: China 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
EUROPE
Table 46: Europe Current & Future Analysis for Single Lead ECG
Equipment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 47: Europe Historic Review for Single Lead ECG Equipment
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 48: Europe 15-Year Perspective for Single Lead ECG
Equipment by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027
Table 49: Europe Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 50: Europe Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 51: Europe 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 52: Europe Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 53: Europe Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 54: Europe 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
FRANCE
Table 55: France Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 56: France Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 57: France 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 58: France Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 59: France Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 60: France 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
GERMANY
Table 61: Germany Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 62: Germany Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 63: Germany 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 64: Germany Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 65: Germany Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 66: Germany 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
ITALY
Table 67: Italy Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 68: Italy Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 69: Italy 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 70: Italy Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 71: Italy Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 72: Italy 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 73: UK Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 74: UK Historic Review for Single Lead ECG Equipment by
Indication - Syncope, Arrhythmia and Other Indications Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 75: UK 15-Year Perspective for Single Lead ECG Equipment
by Indication - Percentage Breakdown of Value Sales for
Syncope, Arrhythmia and Other Indications for the Years 2012,
2020 & 2027
Table 76: UK Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 77: UK Historic Review for Single Lead ECG Equipment by
End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 78: UK 15-Year Perspective for Single Lead ECG Equipment
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Clinics, Home Care and Ambulatory Surgical Centers for the
Years 2012, 2020 & 2027
SPAIN
Table 79: Spain Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 80: Spain Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 81: Spain 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 82: Spain Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 83: Spain Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 84: Spain 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
RUSSIA
Table 85: Russia Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 86: Russia Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 87: Russia 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 88: Russia Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 89: Russia Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 90: Russia 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for Single
Lead ECG Equipment by Indication - Syncope, Arrhythmia and
Other Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 92: Rest of Europe Historic Review for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 93: Rest of Europe 15-Year Perspective for Single Lead
ECG Equipment by Indication - Percentage Breakdown of Value
Sales for Syncope, Arrhythmia and Other Indications for the
Years 2012, 2020 & 2027
Table 94: Rest of Europe Current & Future Analysis for Single
Lead ECG Equipment by End-Use - Hospitals & Clinics, Home Care
and Ambulatory Surgical Centers - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 95: Rest of Europe Historic Review for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 96: Rest of Europe 15-Year Perspective for Single Lead
ECG Equipment by End-Use - Percentage Breakdown of Value Sales
for Hospitals & Clinics, Home Care and Ambulatory Surgical
Centers for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Single
Lead ECG Equipment by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 98: Asia-Pacific Historic Review for Single Lead ECG
Equipment by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 99: Asia-Pacific 15-Year Perspective for Single Lead ECG
Equipment by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027
Table 100: Asia-Pacific Current & Future Analysis for Single
Lead ECG Equipment by Indication - Syncope, Arrhythmia and
Other Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 101: Asia-Pacific Historic Review for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 102: Asia-Pacific 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 103: Asia-Pacific Current & Future Analysis for Single
Lead ECG Equipment by End-Use - Hospitals & Clinics, Home Care
and Ambulatory Surgical Centers - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 104: Asia-Pacific Historic Review for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 105: Asia-Pacific 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
AUSTRALIA
Table 106: Australia Current & Future Analysis for Single Lead
ECG Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 107: Australia Historic Review for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 108: Australia 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 109: Australia Current & Future Analysis for Single Lead
ECG Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 110: Australia Historic Review for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 111: Australia 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
INDIA
Table 112: India Current & Future Analysis for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 113: India Historic Review for Single Lead ECG Equipment
by Indication - Syncope, Arrhythmia and Other Indications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 114: India 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 115: India Current & Future Analysis for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 116: India Historic Review for Single Lead ECG Equipment
by End-Use - Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 117: India 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
SOUTH KOREA
Table 118: South Korea Current & Future Analysis for Single
Lead ECG Equipment by Indication - Syncope, Arrhythmia and
Other Indications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 119: South Korea Historic Review for Single Lead ECG
Equipment by Indication - Syncope, Arrhythmia and Other
Indications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 120: South Korea 15-Year Perspective for Single Lead ECG
Equipment by Indication - Percentage Breakdown of Value Sales
for Syncope, Arrhythmia and Other Indications for the Years
2012, 2020 & 2027
Table 121: South Korea Current & Future Analysis for Single
Lead ECG Equipment by End-Use - Hospitals & Clinics, Home Care
and Ambulatory Surgical Centers - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 122: South Korea Historic Review for Single Lead ECG
Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 123: South Korea 15-Year Perspective for Single Lead ECG
Equipment by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Home Care and Ambulatory Surgical Centers
for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Table 124: Rest of Asia-Pacific Current & Future Analysis for
Single Lead ECG Equipment by Indication - Syncope, Arrhythmia
and Other Indications - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 125: Rest of Asia-Pacific Historic Review for Single Lead
ECG Equipment by Indication - Syncope, Arrhythmia and Other
Indications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 126: Rest of Asia-Pacific 15-Year Perspective for Single
Lead ECG Equipment by Indication - Percentage Breakdown of
Value Sales for Syncope, Arrhythmia and Other Indications for
the Years 2012, 2020 & 2027
Table 127: Rest of Asia-Pacific Current & Future Analysis for
Single Lead ECG Equipment by End-Use - Hospitals & Clinics,
Home Care and Ambulatory Surgical Centers - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 128: Rest of Asia-Pacific Historic Review for Single Lead
ECG Equipment by End-Use - Hospitals & Clinics, Home Care and
Ambulatory Surgical Centers Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR
Table 129: Rest of Asia-Pacific 15-Year Perspective for Single
Lead ECG Equipment by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Clinics, Home Care and Ambulatory
Surgical Centers for the Years 2012, 2020 & 2027
LATIN AMERICA
Table 130: Latin America Current & Future Analysis for Single
Lead ECG Equipment by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 131: Latin America Historic Review for Single Lead ECG
Equipment by Geographic Region - Argentina, Brazil, Mexico and
Rest of Latin America Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 132: Latin America 15-Year Perspective for Single Lead
ECG Equipment by Geographic Region - Percentage Breakdown of
Value Sales for Argentina, Brazil, Mexico and Rest of Latin
America Markets for Years 2012, 2020 & 2027
Table 133: Latin America Current & Future Analysis for Single
Lead ECG Equipment by Indication - Syncope, Arrhythmia and
Other Indications - Independent Analysis of Annual Sales in US$
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032880/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001